Quantcast

Latest Routes of administration Stories

2014-06-10 08:30:15

AVP-825, Using OptiNose's Patented Bi-Directional(TM) Breath Powered(TM) Technology for Intranasal Delivery of Low-dose Sumatriptan, Demonstrates Greater Reduction in Migraine Pain Compared to the Highest Dose of Oral Sumatriptan YARDLEY, Pa., June 10, 2014 /PRNewswire/ -- OptiNose today announced that the COMPASS trial, a head-to-head comparison of the investigational treatment AVP-825 to sumatriptan tablets, currently the most widely used prescription medication for migraine, met...

2014-06-09 12:29:18

LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: U.S. Market for Infusion Therapy Deviceshttp://www.reportbuyer.com/pharma_healthcare/medical_supplies/hospital_supplies/u_s_market_infusion_therapy_devices.html The U.S. infusion therapy device market will be driven by growth in the needleless connector market, which is expected to increase in value by over 50% during the forecast period.In 2012, the U.S. market for infusion therapy devices...

2014-05-04 23:00:50

ReportsnReports.com adds “Transdermal Drug Delivery Market & Clinical Pipeline Insight” report to its research database. Dallas, Texas (PRWEB) May 04, 2014 Transdermal drug delivery system, over the past decades, has emerged as a major tool for treating diseases of the skin. The major underlying factor driving this method is that the human skin is the most readily accessible surface for the delivery of drugs. A transdermal patch is defined as a medicated adhesive patch which is...

2014-04-28 12:32:22

Safety Engineered IV Therapy Portfolio to be showcased at INS BETHLEHEM, Pa., April 28, 2014 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) will sponsor an Exhibitor Theater presentation and simulation lab at the Infusion Nursing Society (INS) 2014 Annual Convention and Industrial Exhibition in Phoenix, AZ, May 3(rd)-8(th). The presentation, "Navigating the Depths: Ultrasound Guided Short PIV Insertions--Implications and Limitations for Practice," will feature a discussion of technology and...

2014-04-08 12:30:53

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/6d9skh/drug_delivery_in) has announced the addition of a new report "Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/6d9skh/drug_delivery_in ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The delivery of drugs to central nervous system (CNS)...

2014-04-04 12:27:41

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/jdrgzp/enteral_feeding ) has announced the addition of the "Enteral Feeding Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) Enteral feeding devices, also called as artificial nutrition support system are used to deliver nutrition or medication to the patients....

2014-03-26 08:28:21

SILVER SPRING, Md., March 26, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for Remodulin(®) (treprostinil) Injection for the treatment of pulmonary arterial hypertension (PAH) by subcutaneous and intravenous administration. Remodulin will be sold in Japan under the brand name Treprost(TM) by Mochida Pharmaceutical Co., Ltd., under an exclusive distribution agreement with...

2014-03-13 16:25:38

LONDON, March 13, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Intravenous Access Devices Market (Intravenous Needles, Intravenous Catheters and Intravenous Infusion Pumps) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 This report studies the market for intravenous (IV) access devices utilized by physicians to deliver medication to the patients' bloodstream through the intravenous route and also to withdraw blood...

2014-01-22 08:29:45

Products include the Biojector® 2000, Vial Adapter and Bioject® Zetajet(TM) TIGARD, Ore., Jan. 22, 2014 /PRNewswire/ -- Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection technology, today announced that Meditrend International, Bioject's Australian/New Zealand Distributor has received the Australian Register of Therapeutic Goods Certificate for the Biojector Needle-free injection Management System (Biojector® 2000),...

2014-01-17 23:03:19

Transparency Market Research published a new market research report called "Intravenous Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its report store. Browse for Full Report: http://www.transparencymarketresearch.com/intravenous-access-devices.html Albany, NY (PRWEB) January 17, 2014 According to a new market report published by Transparency Market Research "Intravenous Access Devices Market (Intravenous...


Latest Routes of administration Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

More Articles (1 articles) »
Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.